EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive metabolomics combined with machine learning for the identification of SARS-CoV-2 and other viruses directly from upper respiratory samples

Catherine A Hogan iD, Anthony T Le, Afraz Khan, LingHui David Su, ChunHong Huang, Malaya K Sahoo, Chieh-Wen Lo, Marwah Karim, Karin Ann Stein, Shirit Einav, Tina M Cowan, Benjamin A Pinsky iD

Journal of Clinical Microbiology · 2025

DOI: 10.1128/jcm.02042-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Catherine A Hogan und 11 weiteren Autor:innen. Beteiligte Einrichtung: British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Machine Learning, Metabolomics, SARS-CoV-2, COVID-19. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, DOD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic profiling of respiratory samples from individuals infected and uninfected with respiratory viral infections may identify biomarker signatures that complement routine clinical diagnostic testing and offer unique insights into pathophysiology. We used liquid chromatography quadrupole time-of-flight mass spectrometry to generate untargeted metabolomic profiles and identified top biomarker signatures differentiating severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) positive from negative samples via machine learning. We then adapted these signatures to liquid chromatography-tandem mass spectrometry for targeted profiling and assessed classification performance, including samples positive for other respiratory viruses and negative for viral testing. A total of 1,226 samples were tested, including 521 positive samples for SARS-CoV-2, 97 for influenza A, 96 for respiratory syncytial virus (RSV), 211 for other respiratory viruses, and 301 negative samples. The top-performing model was the Light Gradient Boosting Model, which showed an area under the receiver operating characteristic curve (AUC) of 0.99 (95% confidence interval [CI], 0.99–1.00), sensitivity of 0.96 (95% CI, 0.91–0.99), and specificity of 0.95 (95% CI, 0.90–0.97). A separate machine learning analysis investigating the performance by viral subtype showed high performance for the identification of influenza A virus with an AUC of 0.97 (95% CI, 0.94–0.99) and RSV with an AUC of 0.99 (95% CI, 0.97–1.00). The two features with the highest ranking were identified as 3-oxo-heneicosanoic acid and 2-(4-hydroxyphenyl) ethanol. These findings extend our understanding of the metabolic impact of respiratory viral infections and support the potential of metabolomics to complement routine clinical diagnostic methods. IMPORTANCE Molecular testing has greatly improved how viruses are diagnosed; however, gaps remain, including limited sensitivity directly from specimens and inability to differentiate active from resolved infection. In this study, we investigated the use of a distinct diagnostic approach, mass spectrometry for detection of metabolites (small molecules) combined with machine learning analysis, for the diagnosis of SARS-CoV-2 and other respiratory viruses. We demonstrated strong performance of this approach directly from upper respiratory swab samples to differentiate SARS-CoV-2-infected versus uninfected individuals. Extension of this approach to influenza and RSV maintained a high level of performance. This research suggests that mass spectrometry-based infectious disease diagnostic testing has clinical potential and that these metabolomic features may reveal novel host-pathogen interactions and therapeutic targets. Applying a similar approach to prospective, multisite cohorts of patients with other infectious diseases carries potential to extend our understanding of the metabolic pathways involved in the host response to infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningMetabolomicsSARS-CoV-2COVID-19Respiratory Tract InfectionsHumansBiomarkersSensitivity and SpecificityChromatography, LiquidFemaleMiddle AgedMaleAdultTandem Mass Spectrometry

Stichwörter der Autor:innen

COVID-19SARS-CoV-2machine learningmetabolomicsnasopharyngealrespiratory virusesvariants of concern

Substanzen

Biomarkers

Autor:innen und Institutionen

  • British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada.
  • University of British Columbia, Vancouver, British Columbia, Canada.
  • Biochemical Genetics Laboratory, Stanford Health Care, Palo Alto, California, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Clinical Virology Laboratory, Stanford Health Care, Palo Alto, California, USA.
  • Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.

ORCID-Profile: Catherine A Hogan, Benjamin A Pinsky

Förderung

  • NIAID NIH HHS
  • DOD

Zitieren

APA

Hogan, C. A., Le, A. T., Khan, A., Su, L. D., Huang, C., Sahoo, M. K., Lo, C. W., Karim, M., Stein, K. A., Einav, S., Cowan, T. M., & Pinsky, B. A. (2025). Comprehensive metabolomics combined with machine learning for the identification of SARS-CoV-2 and other viruses directly from upper respiratory samples. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.02042-24

Vancouver

Hogan CA, Le AT, Khan A, Su LD, Huang C, Sahoo MK, et al. Comprehensive metabolomics combined with machine learning for the identification of SARS-CoV-2 and other viruses directly from upper respiratory samples. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.02042-24

BibTeX
@article{Hogan2025,
  author = {Hogan, Catherine A and Le, Anthony T and Khan, Afraz and Su, LingHui David and Huang, ChunHong and Sahoo, Malaya K and Lo, Chieh-Wen and Karim, Marwah and Stein, Karin Ann and Einav, Shirit and Cowan, Tina M and Pinsky, Benjamin A},
  title = {Comprehensive metabolomics combined with machine learning for the identification of SARS-CoV-2 and other viruses directly from upper respiratory samples},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  doi = {10.1128/jcm.02042-24}
}
Kostenlos starten →